I interviewed Dr. Sumanta Pal, co-director of the Kidney Cancer Program, City of Hope, about a study he led on the effects of continuing immunotherapy in metastatic kidney cancer patients after it has stopped working.
Episode Sponsored By https://www.carta.healthcare/
Episode Resources
- Connect with Arundhati Parmar
- aparmar@medcitynews.com
- https://twitter.com/aparmarbb?lang=en
- https://medcitynews.com/
- Connect with Dr. Sumanta Pal
- https://www.cityofhope.org/sumanta-pal
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
